Follicular Lymphoma

• CLINICAL_TRIALS trial_result · 2017-05-22
  Clinical Trial Update: Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma [Phase 2]

  Phase 2 study evaluating rituximab plus dexamethasone in patients with low-grade non-Hodgkin lymphoma, including follicular and marginal zon…

• CLINICAL_TRIALS trial_result · 2017-05-22
  Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]

  Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…

• CLINICAL_TRIALS trial_result · 2017-05-18
  Clinical Trial Update: Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma [Phase 2]

  Phase 2 trial evaluating idelalisib plus rituximab for previously untreated follicular lymphoma and small lymphocytic lymphoma was terminate…

• CLINICAL_TRIALS trial_result · 2017-05-17
  Clinical Trial Update: DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402

  An update on the completed ECOG-E4402 study reports on DNA analyses to identify biomarkers that influence response to rituximab in patients …

• CLINICAL_TRIALS trial_result · 2017-05-17
  Clinical Trial Update: Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma

  This clinical trial update reports on biomarkers that may predict response to rituximab in samples from patients with indolent follicular ly…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-05-12
  Clinical Trial Update: Safety and Tolerability of HSC835 in Patients With Hematological Malignancies [Phase 1, Phase 2]

  Phase 1/2 trial assessing safety and tolerability of HSC835 in patients with various hematologic malignancies completed with results posted …

• CLINICAL_TRIALS trial_result · 2017-05-10
  Clinical Trial Update: Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]

  Phase 2 trial evaluating bortezomib plus vorinostat as maintenance after autologous stem cell transplant in non-Hodgkin lymphoma showed resu…

• CLINICAL_TRIALS trial_result · 2017-05-08
  Clinical Trial Update: Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]

  Phase 1/2 trial of oral clofarabine in relapsed/refractory non-Hodgkin lymphoma completed with posted results.

• CLINICAL_TRIALS trial_result · 2017-04-18
  Clinical Trial Update: Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma [Phase 2]

  Clinical trial update reporting Phase 2 results for rituximab in combination with denileukin diftitox in previously untreated stage III or I…

• CLINICAL_TRIALS trial_result · 2017-03-23
  Clinical Trial Update: Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon

  A follow-up clinical trial involving Rituximab and alpha interferon for follicular lymphoma has completed.

• CLINICAL_TRIALS trial_result · 2017-03-17
  Clinical Trial Update: Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma [Phase 2]

  A Phase 2 study evaluating ofatumumab as initial systemic therapy for indolent B-cell lymphomas has completed, with results posted in March …

• CLINICAL_TRIALS trial_result · 2017-03-14
  Clinical Trial Update: A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas [Phase 2]

  Phase 2 trial update evaluating intratumoral PF-3512676 plus local radiation in low-grade Non-Hodgkin lymphoma, including follicular/indolen…

• CLINICAL_TRIALS trial_result · 2017-03-13
  Clinical Trial Update: Primary Rituximab and Maintenance [Phase 3]

  A Phase 3 trial evaluating primary rituximab therapy with maintenance for follicular lymphoma has completed.

• CLINICAL_TRIALS trial_result · 2017-03-10
  Clinical Trial Update: Anti-CD22 CAR-T Therapy for CD19-refractory or Resistant Lymphoma Patients [Phase 1]

  Phase 1 clinical trial update of an anti-CD22 CAR-T therapy for CD19-refractory or resistant lymphomas, including diffuse large B-cell lymph…

• CLINICAL_TRIALS trial_result · 2017-03-03
  Clinical Trial Update: Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon [Phase 2]

  Phase 2 clinical trial evaluating high-dose therapy with stem cell support followed by Rituximab and alpha interferon for follicular lymphom…

• CLINICAL_TRIALS trial_result · 2017-02-28
  Clinical Trial Update: CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy [Phase 1]

  Phase 1 trial evaluating CART19 therapy for B-cell hematologic malignancies including various lymphomas and leukemias that are refractory or…

• CLINICAL_TRIALS trial_result · 2017-02-28
  Clinical Trial Update: S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911

  A clinical trial update reporting on biological markers in patients with follicular lymphoma treated on SWOG trials SWOG-8809, SWOG-9800, an…

• CLINICAL_TRIALS trial_result · 2017-02-07
  Clinical Trial Update: Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab [Phase 2]

  A completed Phase 2 clinical trial studied rituximab and/or lenalidomide in patients with follicular lymphoma that is not refractory to ritu…

• CLINICAL_TRIALS trial_result · 2017-01-30
  Clinical Trial Update: BI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular Lymphoma [Phase 3]

  Phase 3 trial comparing BI 695500 to Rituxan as first-line treatment in low tumor burden follicular lymphoma was terminated with results pos…

• CLINICAL_TRIALS trial_result · 2017-01-27
  Clinical Trial Update: Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]

  Phase 2 clinical trial evaluating a conditioning regimen with Iodine-131 tositumomab plus etoposide and cyclophosphamide, followed by autolo…

• CLINICAL_TRIALS trial_result · 2016-12-23
  Clinical Trial Update: Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma [Phase 1]

  Phase 1 study evaluating a combination of bortezomib, rituximab, and yttrium-90 ibritumomab tiuxetan in relapsed or refractory low-grade, fo…

• CLINICAL_TRIALS trial_result · 2016-12-22
  Clinical Trial Update: A Phase II Study of Doxycycline in Relapsed NHL [Phase 2]

  Phase II trial of doxycycline in relapsed non-Hodgkin lymphoma was terminated and results were posted in 2016.

• CLINICAL_TRIALS trial_result · 2016-12-21
  Clinical Trial Update: Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma [Phase 1, Phase 2]

  Clinical trial update for idelalisib (GS-1101) in previously treated indolent non-Hodgkin's lymphoma, including follicular lymphoma, reporti…

• CLINICAL_TRIALS trial_result · 2016-12-06
  Clinical Trial Update: PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma [Phase 1, Phase 2]

  Clinical trial update describing the evaluation of PCAR-119 Bridge Immunotherapy as a pre-transplant treatment for CD19-positive leukemias a…

• CLINICAL_TRIALS trial_result · 2016-12-01
  Clinical Trial Update: CD180 Overexpression in Follicular Lymphoma

  A clinical trial evaluating CD180 overexpression in follicular lymphoma has completed.